RxDoctor Payments Data

John Fang, MD

Gastroenterology · Salt Lake City, UTNPI 1134219736

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,373 of the $11,770 with a category attached, or 71.1%. 12 manufacturers reported payments, led by Sanofi at 32.0% of the total. Reporting peaked in 2020 at $4,927 and has fallen 74.2% since, to $1,270 in 2025. Among gastroenterology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,770in general payments, 2019–2025

Across 43 payments — averaging $273.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$4K
  • Merit Medical Systems Inc$3K
  • Boston Scientific$3K
  • Fujifilm Healthcare Americas Corporation$938
  • Circa Scientific, Inc.$800
  • Romark Laboratories, LC$200
  • plus $327 from 6 others
$263,858in research payments, 2019–2025

Across 50 payments — averaging $5277.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vanda Pharmaceuticals Inc.$248K
  • Lucid Diagnostics Inc.$16K

What the payments were for

  • Consulting fees$8,37371%
  • Travel & lodging$1,19710%
  • Food & beverage$2,16918%
  • Education$310%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,770 in reported general payments places this provider in the 90th percentile of 122 gastroenterology providers in Utah.

See all gastroenterology providers in Utah

Medicare billing

Part B allowed, 2024
$67,648
Medicare patients
236
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexlansoprazole DrDexlansoprazole12$3,849
Sucralfate26$2,839
Omeprazole98$1,406
Lactated RingersRinger's Solution,lactated19$512
Pantoprazole Sodium15$292
Famotidine13$274
Lidocaine Hcl ViscousLidocaine Hcl14$132

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →